NASDAQ : RMTI
Rockwell Medical, Inc. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 7.31 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 29.46M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 27.85M |
| Enterprise Value | 16.99M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 4.03M |
| Shares Outstanding | 4.03M |
| Shares Change (YoY) | +16.28% |
| Shares Change (QoQ) | +0.42% |
| Owned by Insiders (%) | 2.13% |
| Owned by Institutions (%) | 12.96% |
| Float | 3.59M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.41 |
| Forward PS | 0.38 |
| PB Ratio | 0.80 |
| P/TBV Ratio | 1.15 |
| P/FCF Ratio | 18.50 |
| P/OCF Ratio | 9.84 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 11.45 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.25 |
| Quick Ratio | 2.96 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | 6,966.50 |
| Debt / FCF | 9.05 |
| Interest Coverage | -3.99 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -15.53% |
| Return on Assets (ROA) | -5.18% |
| Return on Invested Capital (ROIC) | -6.05% |
| Return on Capital Employed (ROCE) | -9.97% |
| Weighted Average Cost of Capital (WACC) | 11.34% |
| Revenue Per Employee | $441,968 |
| Profits Per Employee | -$33,369 |
| Employee Count | 157 |
| Asset Turnover | 1.27 |
| Inventory Turnover | 16.37 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.73 |
| 52-Week Price Change | -37.75% |
| 50-Day Moving Average | 7.89 |
| 200-Day Moving Average | 8.22 |
| Relative Strength Index (RSI) | 38.65 |
| Average Volume (20 Days) | 30,068 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 70,068 |
| Short Previous Month | 70,807 |
| Short % of Shares Out | 1.74% |
| Short % of Float | 1.95% |
| Short Ratio (days to cover) | 2.77 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 69.39M |
| Gross Profit | 12.29M |
| Operating Income | -4.52M |
| Pretax Income | -5.08M |
| Net Income | -5.24M |
| EBITDA | -2.43M |
| EBIT | -4.52M |
| Loss Per Share | -$1.36 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 24.80M |
| Total Debt | 13.93M |
| Net Cash | 10.86M |
| Net Cash Per Share | $2.70 |
| Equity (Book Value) | 35.09M |
| Book Value Per Share | 8.83 |
| Working Capital | 25.19M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 2.90M |
| Capital Expenditures | -1.36M |
| Depreciation & Amortization | 2.09M |
| Net Borrowing | -1.13M |
| Free Cash Flow | 1.54M |
| FCF Per Share | $0.38 |
Margins
| Measure | Value |
|---|
| Gross Margin | 17.71% |
| Operating Margin | -6.52% |
| Pretax Margin | -7.33% |
| Profit Margin | -7.33% |
| EBITDA Margin | -3.50% |
| EBIT Margin | -6.52% |
| FCF Margin | 2.22% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -16.28% |
| Shareholder Yield | -16.28% |
| Earnings Yield | -19.63% |
| FCF Yield | 5.40% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $20.00 |
| Price Target Difference | 189.44% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jul 1, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -7.5 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |